Recent Quotes (30 days)

You have no recent quotes
chg | %

Knight Therapeutics Inc  

(Public, CVE:GUD)   Watch this stock  
Find more results for GUD
Apr 28 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 3.51 - 7.24
Open     -
Vol / Avg. 0.00/822,875.00
Mkt cap 138.83M
P/E     -
Div/yield     -
EPS 0.00
Shares     -
Beta     -
Inst. own     -
Mar 24, 2016
Q4 2015 KNIGHT THERAPEUTICS Inc Earnings Call - 8:30AM EDT - Add to calendar
Mar 24, 2016
Q4 2015 KNIGHT THERAPEUTICS Inc Earnings Release Add to calendar

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 5506.14% 34451.68%
Operating margin 5715.79% -1258.19%
EBITD margin - -1234.87%
Return on average assets 4.35% -
Return on average equity 4.37% -
Employees 7 -
CDP Score - -


376 Victoria Avenue, suite 220
+1-514-3401112 (Phone)
+1-514-3444675 (Fax)

Website links


KNIGHT THERAPEUTICS Inc is a Canada-based specialty pharmaceutical company. The Company's principal business activity is developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products in Canada and internationally. The Company has a portfolio of products in various stages of development for various geographies that include Impavido, ATryn, Photofrin, FOCUSfactor, NXN-1882 (nNOS/5HT), NXN-4622 (nNOS) and nNOS/iNOS2 Inhibitor. Impavido (miltefosine) is a product for the treatment of leishmaniasis and is approved in a number of countries. Photofrin is a product for the treatment of oesophageal cancer, endobronchial cancer, high-grade dysplasia in Barrett's oesophagus and papillary bladder cancer and is in approved stage. FOCUSfactor is a product for dietary supplement and is in approved stage.

Officers and directors

James C. Gale Independent Chairman of the Board
Age: 65
Jonathan Ross Goodman President, Chief Executive Officer, Director
Age: 46
Jeffrey Kadanoff Chief Financial Officer
Amal Khouri Vice President - Business Development
Robert N. Lande Independent Director
Age: 52
Edward James Schutter Independent Director
Age: 63
Sylvie Tendler Independent Director